Moderna | MRNA - Market Capitalization



Moderna reported $9.52B in Market Capitalization this September of 2025, considering the latest stock price and the number of outstanding shares.


Market Capitalization Change Date
Acadia Pharmaceuticals USD 3.61B 840M Jun/2025
Agios Pharmaceuticals USD 1.93B 234M Jun/2025
Alnylam Pharmaceuticals USD 42.52B 7.39B Jun/2025
Amgen USD 150.13B 17.37B Jun/2025
Arrowhead Research USD 2.18B 433M Jun/2025
Biogen USD 18.41B 1.62B Jun/2025
BioMarin Pharmaceutical USD 10.54B 3.01B Jun/2025
Cspc Pharmaceutical HKD 57.03B 1.39B Mar/2025
Dianthus Therapeutics USD 692M 93M Sep/2025
Divis Laboratories Ltd 1.81T 277.71B Jun/2025
Gilead Sciences USD 137.91B 1.77B Jun/2025
GlaxoSmithKline GBP 56.24B 4.11B Jun/2025
Incyte USD 13.18B 1.46B Jun/2025
Ionis Pharmaceuticals USD 6.29B 1.49B Jun/2025
Kangmei Pharma CNY 26.2B 2.77B Jun/2025
Knight Therapeutics CAD 599.03M 24.75M Sep/2024
Laboratorios Farma EUR 3.06B 257.39M Sep/2025
Moderna USD 10.67B 290M Jun/2025
Organigram Holdings CAD 222.95M 23.4M Sep/2025
Pharma Mar EUR 1.39B 91.01M Jun/2025
Qiagen NV EUR 10.41B 2.39B Jun/2025
Regeneron Pharmaceuticals USD 55.87B 13.47B Jun/2025
Sarepta Therapeutics USD 1.68B 4.51B Jun/2025
Sartorius EUR 13.56B 794.37M Jun/2025
Tilray CAD 647.69M 211.12M Aug/2025
Ultragenyx Pharmaceutical USD 3.44B 38M Jun/2025
United Therapeutics USD 12.96B 934M Jun/2025
Vertex Pharmaceuticals USD 114.33B 10.31B Jun/2025
Zz Pientze Pharmaceu 120.67B 1.25B Jun/2025